Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(11 sites)
United States
City of Hope Comprehensive Cancer Center, Duarte, California UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California UC San Diego Moores Cancer Center, La Jolla, California UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida Emory University Hospital Midtown, Atlanta, Georgia Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia Emory Saint Joseph's Hospital, Atlanta, Georgia Mount Sinai Hospital, New York, New York NYP/Weill Cornell Medical Center, New York, New York UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas